We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GLAXOSMITHKLINE AWARDED $274 MILLION HHS CONTRACT AND NOVARTIS, GOVERNMENT IN $220M FLU PACT
GLAXOSMITHKLINE AWARDED $274 MILLION HHS CONTRACT AND NOVARTIS, GOVERNMENT IN $220M FLU PACT
May 5, 2006
GlaxoSmithKline has been awarded a $274 million contract from the U.S. Department
of Health and Human Services (HHS) to speed the development of new cell culture-based
seasonal and pandemic influenza vaccines and to scale-up cell culture manufacturing
capability at its Marietta, PA facility.
